SMART therapy with budesonide-formoterol is approved for children aged 6 years and above. For younger children, age-appropriate ICS therapy with spacer devices is used. Dr. Dixit Kumar Thakur has extensive experience in paediatric asthma at Pulmovista Clinics and tailors treatment to the child’s age, weight, device capability, and Delhi-specific trigger profile.